Detalhe da pesquisa
1.
Criteria for the use of omics-based predictors in clinical trials.
Nature
; 502(7471): 317-20, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24132288
2.
Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
Oncologist
; 23(2): 179-185, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158372
3.
Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.
BMC Cancer
; 18(1): 82, 2018 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29338703
4.
The molecular basis of breast cancer pathological phenotypes.
J Pathol
; 241(3): 375-391, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27861902
5.
Diverse somatic mutation patterns and pathway alterations in human cancers.
Nature
; 466(7308): 869-73, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20668451
6.
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
BMC Med
; 11: 220, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228635
7.
Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue.
Lab Invest
; 92(9): 1342-57, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22801299
8.
Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach.
Appl Immunohistochem Mol Morphol
; 27(10): 764-772, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30102605
9.
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.
Clin Cancer Res
; 13(20): 6175-81, 2007 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17947484
10.
A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Clin Cancer Res
; 23(15): 4127-4137, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381416
11.
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
J Clin Oncol
; 23(11): 2544-55, 2005 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15753462
12.
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
J Clin Oncol
; 23(25): 5900-9, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16043828
13.
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients.
Clin Cancer Res
; 11(24 Pt 1): 8686-98, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16361555
14.
Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease.
Clin Exp Metastasis
; 33(1): 53-62, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26507436
15.
Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing.
Appl Immunohistochem Mol Morphol
; 24(7): 490-5, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371432
16.
Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.
PLoS One
; 10(6): e0129280, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076459
17.
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
Clin Pharmacol Ther
; 107(4): 730-734, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017048
18.
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.
Pigment Cell Melanoma Res
; 27(4): 653-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628946
19.
Tissue pattern recognition error rates and tumor heterogeneity in gastric cancer.
Appl Immunohistochem Mol Morphol
; 21(1): 21-30, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22820657
20.
A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses.
J Mol Diagn
; 11(4): 290-7, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19460940